Towards Healthcare
Active Pharmaceutical Ingredients (APIs) Market Top Companies

Active Pharmaceutical Ingredients (APIs) Market Size to Hit USD 344.91 Bn by 2032

The report covers APIs Market Companies and Segments by synthesis methods including Biologic, such as Monoclonal Antibodies, Recombinant Proteins and Vaccines, alongside Synthetic options. These APIs are categorized as Generic or Branded and are utilized in Prescription and Over-the-Counter drugs across numerous therapeutic areas such as Cardiovascular Diseases, Oncology, CNS & Neurological Disorders, Orthopedic Disorders, Endocrinology, Respiratory Disorders, Gastrointestinal Disorders, Nephrology, Ophthalmology and others. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Active Pharmaceutical Ingredients (APIs) Market Assessment

  • Overview
  • Global Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type of Synthesis (2021 – 2033)
    • Biologic
      • Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
    • Synthetic
  • Global Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Generic APIs
    • Branded APIs
  • Global Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Prescription Drugs
    • Over-the-Counter Drugs
  • Global Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiovascular Diseases
    • Oncology
    • CNS & Neurological Disorders
    • Orthopedic Disorders
    • Endocrinology
    • Respiratory Disorders
    • Gastrointestinal Disorders
    • Nephrology
    • Ophthalmology
    • Others
  • Global Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • The Middle East and Africa

North America Active Pharmaceutical Ingredients (APIs) Market Assessment

  • Overview
  • North America Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type of Synthesis (2021 – 2033)
    • Biologic
      • Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
    • Synthetic
  • North America Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Generic APIs
    • Branded APIs
  • North America Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Prescription Drugs
    • Over-the-Counter Drugs
  • North America Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiovascular Diseases
    • Oncology
    • CNS & Neurological Disorders
    • Orthopedic Disorders
    • Endocrinology
    • Respiratory Disorders
    • Gastrointestinal Disorders
    • Nephrology
    • Ophthalmology
    • Others

Europe Active Pharmaceutical Ingredients (APIs) Market Assessment

  • Overview
  • Europe Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type of Synthesis (2021 – 2033)
    • Biologic
      • Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
    • Synthetic
  • Europe Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Generic APIs
    • Branded APIs
  • Europe Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Prescription Drugs
    • Over-the-Counter Drugs
  • Europe Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiovascular Diseases
    • Oncology
    • CNS & Neurological Disorders
    • Orthopedic Disorders
    • Endocrinology
    • Respiratory Disorders
    • Gastrointestinal Disorders
    • Nephrology
    • Ophthalmology
    • Others

Asia-Pacific Active Pharmaceutical Ingredients (APIs) Market Assessment

  • Overview
  • Asia-Pacific Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type of Synthesis (2021 – 2033)
    • Biologic
      • Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
    • Synthetic
  • Asia-Pacific Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Generic APIs
    • Branded APIs
  • Asia-Pacific Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Prescription Drugs
    • Over-the-Counter Drugs
  • Asia-Pacific Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiovascular Diseases
    • Oncology
    • CNS & Neurological Disorders
    • Orthopedic Disorders
    • Endocrinology
    • Respiratory Disorders
    • Gastrointestinal Disorders
    • Nephrology
    • Ophthalmology
    • Others

Latin America Active Pharmaceutical Ingredients (APIs) Market Assessment

  • Overview
  • Latin America Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type of Synthesis (2021 – 2033)
    • Biologic
      • Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
    • Synthetic
  • Latin America Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Generic APIs
    • Branded APIs
  • Latin America Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Prescription Drugs
    • Over-the-Counter Drugs
  • Latin America Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiovascular Diseases
    • Oncology
    • CNS & Neurological Disorders
    • Orthopedic Disorders
    • Endocrinology
    • Respiratory Disorders
    • Gastrointestinal Disorders
    • Nephrology
    • Ophthalmology
    • Others

The Middle East and Africa Active Pharmaceutical Ingredients (APIs) Market Assessment

  • Overview
  • The Middle East and Africa Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type of Synthesis (2021 – 2033)
    • Biologic
      • Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
    • Synthetic
  • The Middle East and Africa Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Generic APIs
    • Branded APIs
  • The Middle East and Africa Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Prescription Drugs
    • Over-the-Counter Drugs
  • The Middle East and Africa Active Pharmaceutical Ingredients (APIs) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Cardiovascular Diseases
    • Oncology
    • CNS & Neurological Disorders
    • Orthopedic Disorders
    • Endocrinology
    • Respiratory Disorders
    • Gastrointestinal Disorders
    • Nephrology
    • Ophthalmology
    • Others

Company Profiles

  • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Pfizer Inc
  • Novartis International AG
  • BASF SE
  • Dr. Reddy's Laboratories Ltd
  • Lonza
  • Merck KGaA
  • Boehringer Ingelheim
  • Sun Pharmaceutical Industries Ltd

Conclusion & Recommendations

  • Insight Code: 5091
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: January 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Active pharmaceutical ingredients (APIs), which are chemical compounds essential for medication, are primarily produced in the United States, Europe, China and India. These pharmacologically active substances are commonly used with other ingredients to diagnose, cure and treat diseases. Pharmaceutical companies have recently begun importing APIs from producing countries. Modern medicines comprise two main components of disease prevention, treatment, diagnosis and cure. The API or active and biologically effective core, is responsible for carrying out the necessary actions in the body. Excipients, such as lactose or mineral oil, are chemically inactive substances that add volume, flavour or colour while assisting in API delivery throughout the body.

Active pharmaceutical ingredients (APIs) face challenges such as stringent regulatory requirements, rising development costs, increasing competition and the need for continuous innovation. Supply chain disruption, quality control issues and manufacturing process complexities contribute to this industry hurdles. Additionally, geopolitical factors, intellectual property concerns and the time-consuming drug approval process pose significant challenges for companies in the API market.

Monoclonal antibodies have significantly impacted the active pharmaceutical ingredients (APIs) market by driving therapeutic advancement. Because of their precise targeting in treating various diseases, including cancer and autoimmune disorders, there has been an increase in demand for the active pharmaceutical ingredients (APIs) used in their production. This trend will continue as research and development efforts focus on expanding monoclonal antibody therapeutic applications. Monoclonal antibodies have been used to treat various diseases, including cancer, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. This wide range of applications helps to fuel the growing demand for APIs.

Food and Drug Administration, ScienceDirect Publication, World Health Organisation, National Institute of Health, Gov. info, Health Sciences Authority, Department of Pharmaceuticals.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509